Continued Increase In Sales Earns CVS A Bullish Thesis
Equity Watch - at Seeking Alpha - Thu Dec 25, 2:08AM CST
CVS: 97.89 (+0.02)
Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)
CVS Caremark Has Returned 24.7% Since SmarTrend Recommendation (CVS)
Comtex SmarTrend(R) - Wed Dec 24, 9:42AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 5 months, CVS Caremark has returned 24.69% as of today's recent price of $97.98.
CVS: 97.89 (+0.02)
Update: Walgreen Earnings Put The Green In Walgreen
The Specialist - at Seeking Alpha - Tue Dec 23, 1:39PM CST
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
Walgreen Q1 Earnings Top On Strong Prescription Sales
at Investor's Business Daily - Tue Dec 23, 10:50AM CST
A record number of prescriptions helped boost Walgreen 's (WAG) first-quarter results above analyst estimates. On Tuesday, the drugstore chain reported a 12.5% increase in earnings to 81 cents per share. Analysts polled by Thomson Reuters were...
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
Today's Market: Moving Higher On Strong Earnings And Pricing Power
Matthew Smith - at Seeking Alpha - Tue Dec 23, 10:48AM CST
SPY: 207.77 (+0.02), HTZ: 24.38 (-0.09), JPM: 62.48 (unch), GMCR: 137.65 (+1.10), DIA: 180.03 (unch), SNE: 21.32 (+0.46), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16)
Express Scripts Hates Gilead Sciences, Loves AbbVie
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 10:22AM CST
Source: Express Scripts When Gilead Sciences won approval last winter for its game-changing hepatitis C drug, Sovaldi, healthcare payers recoiled at Sovaldi's $1,000 per pill pricing. Express Scripts offered one of the loudest voices of...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02)
Jim Cramer on the Markets: Some Stocks You Just Can't Ignore
at The Street - Tue Dec 23, 9:03AM CST
And stop chasing stocks that won't let you in.
FDX: 176.42 (-0.52), MMM: 166.96 (+0.09), SWKS: 74.32 (+0.92), NKE: 96.29 (+0.32), HON: 101.96 (-0.02), DIS: 94.42 (-0.27), BA: 131.24 (+1.21), MS: 38.81 (-0.14), AA: 15.77 (+0.04), CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), COST: 143.65 (-0.50), CVS: 97.89 (+0.02), MCD: 93.83 (-0.39), GOOGL: 536.93 (-1.84), ROST: 92.72 (-0.60)
Rite Aid: A Classic Value Trap
James Godbout - at Seeking Alpha - Tue Dec 23, 8:33AM CST
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
'Fast Money' Recap: The World's Investment Money Is Coming to the U.S.
at The Street - Tue Dec 23, 4:00AM CST
The trading panel discussed stocks, the price of oil, Twitter and Abbvie's price cuts on hepatitus C drugs.
BID: 43.31 (+0.01), XOP: 49.05 (-0.89), FB: 80.77 (+0.16), BBRY: 10.67 (-0.13), WMT: 86.43 (-0.23), TIF: 107.27 (+0.28), INTC: 37.44 (+0.01), TLT: 123.95 (+0.41), TCO: 75.81 (-0.37), SBUX: 81.27 (-0.16), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), QCOM: 74.66 (+0.06), TGT: 74.65 (-0.04), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), GOOGL: 536.93 (-1.84), TWTR: 37.61 (+0.04)
Watch for CVS Caremark to Potentially Pullback After Gaining 1.47% Yesterday
Comtex SmarTrend(R) - Mon Dec 22, 4:02PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.76 to a high of $97.11. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $96.73 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.89 (+0.02)
Look for Shares of CVS Caremark to Potentially Pullback after Yesterday's 1.47% Rise
Comtex SmarTrend(R) - Mon Dec 22, 4:01PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.76 to a high of $97.11. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $96.73 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.89 (+0.02)
The 3 Best Ways to Invest In Real Estate
Motley Fool Staff - Motley Fool - Mon Dec 22, 1:01PM CST
Real estate can be a great investment and has the potential for excellent income and long-term growth. However, buying investment properties is not for everyone. We asked three of our analysts for their favorite way to invest in real estate, and...
HCP: 44.00 (-0.45), NNN: 40.27 (+0.15), STI: 42.43 (-0.18), CVS: 97.89 (+0.02), RLGY: 43.91 (+0.39)
Walgreen Lags CVS Health, but Both Are Technically Overbought
at The Street - Mon Dec 22, 12:34PM CST
CVS Health expanded its Minute Clinic and quit selling cigarettes, while Walgreen still sells smokes and will move to the Nasdaq after completing a merger. Here's how to trade them.
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16)
Rite Aid After Earnings: Alive To Fight Another Day
Hunter Straus - at Seeking Alpha - Mon Dec 22, 8:45AM CST
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
3 Reasons Rite Aid Corporation's Stock Could Soar in 2015
Keith Speights, The Motley Fool - Motley Fool - Mon Dec 22, 7:02AM CST
Rite Aid Corporation shareholders can celebrate big gains of more than 30% for 2015 headed into the last few days of the year thanks in part to a blow-out third quarter. However, some investors might still be disappointed. Why? Because the stock of...
MCK: 209.79 (+0.58), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
Should You Consider Walgreen For The Trifecta?
The Specialist - at Seeking Alpha - Sun Dec 21, 2:53PM CST
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
Walgreen Earnings Due Amid Merger, Management Shakeup
at Investor's Business Daily - Sun Dec 21, 7:02AM CST
Investors will look for signs of renewed growth at Walgreen (WAG) when it reports first-quarter financial results Tuesday after just barely meeting expectations last quarter. The report comes amid a shakeup in top Walgreen management as it enters the...
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)
Retail trends to watch: Athleisure, P-E buyouts, and new online channels
Seeking Alpha - at Seeking Alpha - Sat Dec 20, 9:17AM CST
SPLS: 17.82 (-0.01), AMZN: 303.03 (-3.26), NKE: 96.29 (+0.32), DKS: 49.47 (-0.30), ANN: 38.11 (+0.58), WSM: 75.32 (-0.61), ARO: 2.30 (-0.03), XRT: 95.24 (-0.06), LULU: 54.40 (-0.16), RAD: 7.26 (-0.09), UA: 67.97 (+0.18), ANF: 28.06 (-0.17), CVS: 97.89 (+0.02), ODP: 8.75 (+0.06), ULTA: 128.18 (-0.38), WAG: 76.67 (+0.16), PETM: 81.16 (+0.03)
Jim Cramer Identifies Buying Opportunity in Walgreen (WAG) Stock After Earnings Next Week
at The Street - Fri Dec 19, 11:51AM CST
TheStreet's Jim Cramer explains when to buy Walgreen (WAG) stock after earnings next week.
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)